NLRP3 and cancer: In conclusion, SOAT1 could promote OSCC malignancy and regulate the activation of NLRP3 inflammasome to increase the rate of lymphangiogenesis and cancer metastasis via IL‐1β/IL‐1R‐1 axis in OSCC.